東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Retinal degenerative diseases XIX = ...

International Symposium on Retinal Degenerations (2021 :)

Linked to FindBook

Google Book

Amazon

博客來

Retinal degenerative diseases XIX = mechanisms and experimental therapy /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Retinal degenerative diseases XIX/ edited by John D. Ash ... [et al.].
Reminder of title:	mechanisms and experimental therapy /
remainder title:	Retinal degenerative diseases 19
other author:	Ash, John D.
corporate name:	International Symposium on Retinal Degenerations
Published:	Cham :Springer International Publishing : : 2023.,
Description:	xix, 588 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Retinal degeneration - Congresses. -
Online resource:	https://doi.org/10.1007/978-3-031-27681-1
ISBN:	9783031276811

Retinal degenerative diseases XIX = mechanisms and experimental therapy /
Retinal degenerative diseases XIXmechanisms and experimental therapy /[electronic resource] :Retinal degenerative diseases 19edited by John D. Ash ... [et al.]. - Cham :Springer International Publishing :2023. - xix, 588 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v. 14152214-8019 ;. - Advances in experimental medicine and biology ;v. 1415..

This book contains the proceedings of the XIX International Symposium on Retinal Degeneration. A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. These retinal degeneration symposia are known by most as the "best" and "most important" meetings in the field. The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. We anticipate that the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.

ISBN: 9783031276811

Standard No.: 10.1007/978-3-031-27681-1doiSubjects--Topical Terms:

804421
Retinal degeneration
--Congresses.

LC Class. No.: RE661.D3

Dewey Class. No.: 617.735

Retinal degenerative diseases XIX = mechanisms and experimental therapy /
LDR:02357nmm a2200337 a 4500 001 2332584
003 DE-He213
005 20230713093619.0
006 m d
007 cr nn 008maaau
008 240402s2023 sz s 0 eng d
020 $a 9783031276811 $q (electronic bk.)
020 $a 9783031276804 $q (paper)
024 7 $a 10.1007/978-3-031-27681-1 $2 doi
035 $a 978-3-031-27681-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RE661.D3
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
072 7 $a PSAN $2 thema
082 0 4 $a 617.735 $2 23
090 $a RE661.D3 $b I61 2021
111 2 $a International Symposium on Retinal Degenerations $n (19th : $d 2021 : $c Nashville, Tenn. ; Online) $3 3662577
245 1 0 $a Retinal degenerative diseases XIX $h [electronic resource] : $b mechanisms and experimental therapy / $c edited by John D. Ash ... [et al.].
246 3 $a Retinal degenerative diseases 19
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a xix, 588 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 2214-8019 ; $v v. 1415
520 $a This book contains the proceedings of the XIX International Symposium on Retinal Degeneration. A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. These retinal degeneration symposia are known by most as the "best" and "most important" meetings in the field. The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. We anticipate that the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.
650 0 $a Retinal degeneration $v Congresses. $3 804421
650 1 4 $a Neuroscience. $3 917253
650 2 4 $a Immunology. $3 611031
650 2 4 $a Ophthalmology. $3 862704
700 1 $a Ash, John D. $3 2059055
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Advances in experimental medicine and biology ; $v v. 1415. $3 3662578
856 4 0 $u https://doi.org/10.1007/978-3-031-27681-1
950 $a Biomedical and Life Sciences (SpringerNature-11642)